The candidate genes <it>TAF5L, TCF7, PDCD1</it>, <it>IL6 </it>and <it>ICAM1 </it>cannot be excluded from having effects in type 1 diabetes
<p>Abstract</p> <p>Background</p> <p>As genes associated with immune-mediated diseases have an increased prior probability of being associated with other immune-mediated diseases, we tested three such genes, <it>IL23R</it>, <it>IRF5 </it>and <...
Main Authors: | Vella Adrian, Zeitels Lauren R, Masters Jennifer, Godfrey Lisa M, Downes Kate, Payne Felicity, Bailey Rebecca, Smyth Deborah J, Cooper Jason D, Walker Neil M, Todd John A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-11-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/8/71 |
Similar Items
-
Benzoisoquinolinediones as potent and selective inhibitors of BRPF2 and TAF1/TAF1L bromodomains
by: Bouché, L, et al.
Published: (2017) -
The roles of TAF1 in neuroscience and beyond
by: Elisa M. Crombie, et al.
Published: (2024-09-01) -
ICAM-1 and ICAM-2 Are Differentially Expressed and Up-Regulated on Inflamed Pulmonary Epithelium, but Neither ICAM-2 nor LFA-1: ICAM-1 Are Required for Neutrophil Migration Into the Airways In Vivo
by: Deborah L. W. Chong, et al.
Published: (2021-08-01) -
Failure to block adhesion of Plasmodium falciparum-infected erythrocytes to ICAM-1 with soluble ICAM-1.
by: Craig, A, et al.
Published: (1997) -
SR Protein Kinase 1 Inhibition by TAF15
by: Anastasia Koukiali, et al.
Published: (2022-12-01)